Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;48(4):1417-9.
doi: 10.1128/JCM.01709-09. Epub 2010 Jan 27.

Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species

Affiliations

Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species

Zhi-Dong Jiang et al. J Clin Microbiol. 2010 Apr.

Abstract

This study examined established enteric pathogens, Arcobacter species and enterotoxigenic Bacteroides fragilis (ETBF), in 201 U.S. and European travelers with acute diarrhea acquired in Mexico, Guatemala, and India. Arcobacter butzleri and ETBF were detected in 8% and 7% of diarrhea cases, respectively.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Burnens, A. P., P. Boss, F. Orskov, I. Orskov, U. B. Schaad, F. Muller, R. Heinzle, and J. Nicolet. 1992. Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis. Eur. J. Clin. Microbiol. Infect. Dis. 11:631-634. - PubMed
    1. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, F. J. de la Cabada, and D. A. Conrad. 1992. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 267:1932-1935. - PubMed
    1. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, and M. W. DuPont. 1992. Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study. Antimicrob. Agents Chemother. 36:87-91. - PMC - PubMed
    1. DuPont, H. L., R. Haake, D. N. Taylor, C. D. Ericsson, Z. D. Jiang, P. C. Okhuysen, and R. Steffen. 2007. Rifaximin treatment of pathogen-negative travelers' diarrhea. J. Travel Med. 14:16-19. - PubMed
    1. Dupont, H. L., Z. D. Jiang, J. Belkind-Gerson, P. C. Okhuysen, C. D. Ericsson, S. Ke, D. B. Huang, M. W. Dupont, J. A. Adachi, F. J. De La Cabada, D. N. Taylor, S. Jaini, and F. Martinez Sandoval. 2007. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin. Gastroenterol. Hepatol. 5:451-456. - PubMed

Publication types